how much weight do you lose on tirzepatide Can Help Weight? Tirzepatide Dosage Guide and Chart

It is the first GLP-1 receptor agonist tablet for weight-loss to be approved by the Medicines and Healthcare products Regulatory Agency (MHRA), making the UK the third country to authorise the pills, behind the US and the United Arab Emirates

Thiart H, Ebert DD, Lehr D, et al

No, Retatrutide has not received approval from Health Canada or any regulatory body as of January 2026

OptumRx and UnitedHealthcare are registered marks of UnitedHealth Group Incorporated

Maintaining open communication ensures both medications are optimised for your individual needs, maximising benefits whilst minimising risks

This knowledge makes weight loss management safer and more effective because decisions about treatment options consider your complete picture rather than isolated symptoms